Alfonso Gúrpide

Universidad de Navarra — Spain

Medicine · Health Sciences

27h-index3.6kcitations139works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(37), Cancer Genomics and Diagnostics(22), Lung Cancer Research Studies(17), Cancer Immunotherapy and Biomarkers(16), Lung Cancer Diagnosis and Treatment(16)

Publications139 total

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
EBioMedicine·2024· 2 citedOpen Access
First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies
Clinical Genitourinary Cancer·2023· 7 cited
232P Identification of ‘secondary’ germline cancer predisposition variants from somatic tumour testing: Should we evolve towards universal screening?
Annals of Oncology·2023Open Access
Whole exome sequencing and machine learning germline analysis of individuals presenting with phenotypes of extreme high and low risk of developing tobacco-induced lung adenocarcinoma.
Journal of Clinical Oncology·2023Open Access
Data from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
Supplementary Figures 1-6 from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
Data from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
Supplementary Methods from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
Supplementary Methods from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
Supplementary Figures 1-6 from Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
2023Open Access
PSA reactivity in extracellular microvesicles to commercial immunoassays
Clinica Chimica Acta·2023· 11 citedOpen Access
YES1 Is a Druggable Oncogenic Target in SCLC
Journal of Thoracic Oncology·2022· 20 cited
Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit
Journal of Clinical Medicine·2022· 1 citedOpen Access
P12.03 The Time of Anti-PD-1 Infusion Improves Survival Outcomes by Fasting Conditions Simulation in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2021
967P The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer
Annals of Oncology·2021· 10 cited
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research·2021· 5 citedOpen Access
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Cytokine·2021· 18 citedOpen Access
71 Whole exome sequencing of individuals presenting extreme phenotypes of high and low-risk of developing tobacco-induced lung adenocarcinoma: relevance of immune and DNA-repair related pathways
Regular and Young Investigator Award Abstracts·2020Open Access
Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients
Clinical Chemistry and Laboratory Medicine (CCLM)·2020· 10 cited
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology·2019· 69 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

José Luis Perez‐Gracia(26), José M. López-Picazo(15), Ignacio Melero(13), Salvador Martín‐Algarra(12), María D. Lozano(12), Álvaro González(10), Ignacio Gil‐Bazo(9), Rubén Pı́o(8), Miguel F. Sanmamed(7), Maria Pilar Andueza(7), María E. Rodríguez-Ruiz(6), Jesús García‐Foncillas(6), Ana Patiño‐García(6), Alfonso Calvo(6), Pedro Berraondo(5), Juan P. Fusco(5), Carlos Alfaro(5), Luis M. Montuenga(5), José I. Echeveste(5), Margarita Majem(5)